Electric light, particularly at night, disrupts human circadian rhythmicity: is that a problem? DOI Open Access

Richard G. Stevens,

Yong Zhu

Philosophical Transactions of the Royal Society B Biological Sciences, Journal Year: 2015, Volume and Issue: 370(1667), P. 20140120 - 20140120

Published: March 17, 2015

Over the past 3 billion years, an endogenous circadian rhythmicity has developed in almost all life forms which daily oscillations physiology occur. This allows for anticipation of sunrise and sunset. physiological is kept at precisely 24 h by cycle sunlight dark. However, since introduction electric lighting, there been inadequate light during day inside buildings a robust resetting human rhythmicity, too much night true dark to be detected; this results disruption alters sleep/wake cycle, core body temperature, hormone regulation release, patterns gene expression throughout body. The question extent compromises health, can account portion modern pandemics breast prostate cancers, obesity, diabetes depression. As societies modernize (i.e. electrify) these conditions increase prevalence. There are number promising leads on putative mechanisms, epidemiological findings supporting aetiologic role lighting disease causation. These include melatonin suppression, expression, connection metabolism part affected haem iron intake distribution.

Language: Английский

Hepatic stellate cells as key target in liver fibrosis DOI Creative Commons

Takaaki Higashi,

Scott L. Friedman, Yujin Hoshida

et al.

Advanced Drug Delivery Reviews, Journal Year: 2017, Volume and Issue: 121, P. 27 - 42

Published: May 12, 2017

Language: Английский

Citations

1187

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019 DOI Creative Commons
Bedair Dewidar, Christoph Meyer, Steven Dooley

et al.

Cells, Journal Year: 2019, Volume and Issue: 8(11), P. 1419 - 1419

Published: Nov. 11, 2019

Liver fibrosis is an advanced liver disease condition, which could progress to cirrhosis and hepatocellular carcinoma. To date, there no direct approved antifibrotic therapy, current treatment mainly the removal of causative factor. Transforming growth factor (TGF)-β a master profibrogenic cytokine promising target treat fibrosis. However, TGF-β has broad biological functions its inhibition induces non-desirable side effects, override therapeutic benefits. Therefore, understanding pleiotropic effects upstream downstream regulatory mechanisms will help design better based therapeutics. Here, we summarize recent discoveries milestones on signaling pathway related hepatic stellate cell (HSC) activation, emphasizing research last five years. This comprises impact fibrogenesis processes, such as senescence, metabolism, reactive oxygen species generation, epigenetics, circadian rhythm, epithelial mesenchymal transition, endothelial-mesenchymal transition. We also describe influence microenvironment response HSC TGF-β. Finally, discuss new approaches pathway, name clinical trials, explain promises drawbacks that deserve be adequately addressed.

Language: Английский

Citations

598

The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome DOI Creative Commons
Baokun He,

Kazunari Nohara,

Noheon Park

et al.

Cell Metabolism, Journal Year: 2016, Volume and Issue: 23(4), P. 610 - 621

Published: April 1, 2016

Language: Английский

Citations

441

The nuclear receptor superfamily: A structural perspective DOI Open Access

Emily R. Weikum,

Xu Liu, Eric A. Ortlund

et al.

Protein Science, Journal Year: 2018, Volume and Issue: 27(11), P. 1876 - 1892

Published: Aug. 15, 2018

Abstract Nuclear receptors (NRs) are a family of transcription factors that regulate numerous physiological processes such as metabolism, reproduction, inflammation, well the circadian rhythm. NRs sense changes in lipid metabolite levels to drive differential gene expression, producing distinct physiologic effects. This is an allosteric process whereby binding cognate ligand and specific DNA sequences drives recruitment diverse transcriptional co‐regulators at chromatin ultimately transactivation or transrepression target genes. Dysregulation NR signaling leads various malignances, metabolic disorders, inflammatory disease. Given their important role physiology ability respond small lipophilic ligands, have emerged valuable therapeutic targets. Here, we summarize discuss recent progress on understanding complex mechanism action NRs, primarily from structural perspective. Finally, suggest future studies improve our better design drugs by integrating multiple biophysical approaches.

Language: Английский

Citations

384

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes DOI

Amy K. Rines,

Kfir Sharabi,

Clint D.J. Tavares

et al.

Nature Reviews Drug Discovery, Journal Year: 2016, Volume and Issue: 15(11), P. 786 - 804

Published: Aug. 12, 2016

Language: Английский

Citations

318

Circadian rhythm as a therapeutic target DOI
Wei Ruan, Xiaoyi Yuan, Holger K. Eltzschig

et al.

Nature Reviews Drug Discovery, Journal Year: 2021, Volume and Issue: 20(4), P. 287 - 307

Published: Feb. 15, 2021

Language: Английский

Citations

299

Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses DOI Creative Commons
Mauricio Farez,

Iván Mascanfroni,

Santiago P. Méndez‐Huergo

et al.

Cell, Journal Year: 2015, Volume and Issue: 162(6), P. 1338 - 1352

Published: Sept. 1, 2015

Language: Английский

Citations

289

Oxysterols: From cholesterol metabolites to key mediators DOI

Valentin Mutemberezi,

Owein Guillemot‐Legris, Giulio G. Muccioli

et al.

Progress in Lipid Research, Journal Year: 2016, Volume and Issue: 64, P. 152 - 169

Published: Sept. 26, 2016

Language: Английский

Citations

280

Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry DOI
Patrick Mäder, Lars Kattner

Journal of Medicinal Chemistry, Journal Year: 2020, Volume and Issue: 63(23), P. 14243 - 14275

Published: Sept. 1, 2020

Sulfoximines have been largely disregarded in medicinal chemistry for a long time. However, recently, they risen to the apparent level of stardom on drug discovery scene. Considering outstanding properties sulfoximines, this versatile functional group has advanced implementation several programs. Currently, fashionable can be found various hit-to-lead and lead optimization studies early stages compounds currently clinical trials. Herein, we review recent developments demonstrate scope limitations interesting discovery.

Language: Английский

Citations

279

Nuclear receptors and nonalcoholic fatty liver disease DOI
Matthew C. Cave,

Heather B. Clair,

Josiah Hardesty

et al.

Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, Journal Year: 2016, Volume and Issue: 1859(9), P. 1083 - 1099

Published: March 5, 2016

Language: Английский

Citations

258